HealthcareServices

Global Solid Tumor Cancer Treatment Market Set for Strong Expansion, Reaching $501.27 Billion With 13.6% CAGR by 2030

March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the solid tumor cancer treatment market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Solid Tumor Cancer Treatment Market’s size between 2026 and 2030?

The solid tumor cancer treatment market has shown rapid expansion in recent years. Its size is expected to increase from $265.41 billion in 2025 to $301.06 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.4%. Historically, this growth can be ascribed to an escalating incidence of cancer, the uptake of chemotherapy, innovations in radiation therapy, a rise in oncology funding, and enhancements in early diagnosis.

The solid tumor cancer treatment market size is poised for substantial expansion over the next few years. It is projected to reach $501.28 billion by 2030, achieving a compound annual growth rate (CAGR) of 13.6%. This anticipated growth during the forecast period is attributed to several factors including immunotherapy approvals, the development of targeted drug pipelines, the increasing adoption of personalized medicine, the expansion of oncology infrastructure, and improvements in survival rates. Prominent trends expected in this period involve the growth of checkpoint inhibitors, the expansion of tumor-agnostic therapies, a greater utilization of combination regimens, the rising incidence of biomarker-driven treatment, and the growth of outpatient oncology services.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9909&type=smp

Which Drivers Are Shaping Strategic Decisions In The Solid Tumor Cancer Treatment Market?

The rising occurrence of cancer notably propels the expansion of the solid tumor cancer treatment market in the future. Cancer is a serious illness characterized by the rapid and unrestrained multiplication of the body’s cells, leading to irregular formations. Solid tumor cancer treatment denotes a therapeutic approach designed to extract solid tumors from the bodies of cancer patients. For example, in April 2024, data from the World Health Organization, an international public health entity headquartered in Switzerland, indicated that approximately 20 million new cancer diagnoses were recorded in 2022, causing around 10 million fatalities from the condition. Projections based on demographics forecast that the yearly incidence of cancer might escalate to 35 million by 2050, signifying a 77% surge compared to 2022 statistics. Lung cancer emerged as the most frequently identified type, making up roughly 2.5 million new instances, which is equivalent to one in every eight global cancer diagnoses, constituting 12.4% of all cancers globally. Consequently, the escalating incidence of cancer acts as a key driver for the expansion of the solid tumor cancer treatment market.

What Segment Classifications Make Up The Solid Tumor Cancer Treatment Market?

The solid tumor cancer treatment market covered in this report is segmented –

1) By Type: Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Surgical Procedures

2) By Application: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other Applications

3) By End-Users: Hospitals, Research Institutes, Homecare

Subsegments:

1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anthracyclines, Mitotic Inhibitors

2) By Targeted Therapy: Monoclonal Antibodies, Small Molecule Inhibitors, Signal Transduction Inhibitors

3) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines

4) By Hormone Therapy: Aromatase Inhibitors, Anti-Androgens, Selective Estrogen Receptor Modulators (SERMs)

5) By Surgical Procedures: Tumor Resection, Laparoscopic Surgery, Robotic-Assisted Surgery

How Are Emerging Trends Affecting The Progression Of The Solid Tumor Cancer Treatment Market?

Key companies active in the solid tumor cancer treatment sector are focusing their efforts on devising advanced immunotherapies, targeted therapies, and cell-based approaches to improve patient well-being and expand available therapeutic options. For example, in July 2025, Dispatch Bio, a US-based biotechnology company, began its operations specifically to develop universal treatments for solid tumors. The company aims to further novel therapeutic strategies that target a broad spectrum of solid tumor types, enhance efficacy across various patient populations, and accelerate the development of scalable cancer immunotherapies, potentially transforming current standard-of-care treatment and improving long-term survival rates.

Which Leading Companies Dominate The Solid Tumor Cancer Treatment Market Share?

Major companies operating in the solid tumor cancer treatment market are AstraZeneca plc, Amgen Inc., Bristol Myers Squibb & Company, Eli Lilly & Company, F Hoffmann La Roche Ltd, Merck & Co Inc, Novartis AG, Pfizer Inc, Olympus Medical Systems, Astellas Pharma Inc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Ltd, Celldex Therapeutics Inc, AbbVie Inc, Bayer AG, Eisai Co Ltd, Exelixis Inc, Genentech Inc, Gilead Sciences Inc, Incyte Corporation, Ipsen Biopharmaceuticals Inc, Karyopharm Therapeutics Inc, Kyowa Kirin Co Ltd, MorphoSys AG, Regeneron Pharmaceuticals Inc, Sanofi SA, Seattle Genetics Inc, Spectrum Pharmaceuticals Inc, Taiho Pharmaceutical Co Ltd, Verastem Inc, Zymeworks Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report

How Does The Solid Tumor Cancer Treatment Market Perform Across Major Global Regions?

North America was the largest region in the solid tumor cancer treatment market in 2025. The regions covered in the solid tumor cancer treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Solid Tumor Cancer Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9909&type=smp

Browse Through More Reports Similar to the Global Solid Tumor Cancer Treatment Market 2026, By The Business Research Company

Intratumoral Cancer Therapies Market Report 2026

https://www.thebusinessresearchcompany.com/report/intratumoral-cancer-therapies-global-market-report

Solid Tumor Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report

Bone Cancer Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/bone-cancer-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795